{"id":"W2975057760","doi":"10.1007/s40273-019-00841-1","title":"Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"TransCanada (Canada)","funders":"Takeda Pharmaceutical Company; Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Health economics; Adalimumab; Ulcerative colitis; Discontinuation; Golimumab; Infliximab; Tofacitinib; Quality-adjusted life year; Cost effectiveness; Internal medicine; Public health; Disease; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001699812,0.0002253524,0.0004533264,0.0002258703,0.00002154726,0.00001800701,0.0001746358,0.00008326953,0.00006816123],"category_scores_gemma":[0.000008972607,0.0002020937,0.00006543343,0.000240338,0.00006427538,0.00001605306,0.00006493353,0.00009357312,0.00001294588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001239688,"about_ca_system_score_gemma":0.0001257632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001193048,"about_ca_topic_score_gemma":0.001271734,"domain_scores_codex":[0.9987316,0.00017827,0.0002912654,0.0004568403,0.00006484553,0.0002772094],"domain_scores_gemma":[0.999323,0.00003130902,0.0001562984,0.0002737727,0.0001199168,0.00009575688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00734118,0.000186728,0.7813549,0.00003031656,0.0004454321,0.000004208553,0.0001579299,0.2082195,0.002039735,0.00002818351,0.000007455411,0.0001844268],"study_design_scores_gemma":[0.005962078,0.0001913849,0.9762158,0.0000254459,0.0001088331,5.014007e-7,0.00009810752,0.008005257,0.008944715,0.000005333283,0.0001288435,0.0003136971],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976902,0.000009242388,0.0001032757,0.000007012142,0.00004573565,0.001314238,0.0004692078,0.000006281499,0.0003548124],"genre_scores_gemma":[0.9991263,0.000009135077,0.0001127066,0.000245384,0.00001407469,0.0001174216,0.0003301267,0.00002847093,0.0000164465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2002143,"threshold_uncertainty_score":0.8241142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0149218097090462,"score_gpt":0.2817782373427612,"score_spread":0.266856427633715,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}